Wallace Capital Management’s Utah Medical Products UTMD Stock Holding History

Wallace Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-9,013	Closed	-$537K	–	57
2015 Q2	$537K	Buy	9,013 +3	+0%	+$169	0.09%	44
2015 Q1	$539K	Hold	9,010	–	–	0.09%	44
2014 Q4	$541K	Buy	9,010 +4	+0%	+$222	0.1%	43
2014 Q3	$439K	Sell	9,006 -482	-5%	-$24.5K	0.09%	45
2014 Q2	$488K	Sell	9,488 -513	-5%	-$26.3K	0.1%	45
2014 Q1	$578K	Hold	10,001	–	–	0.13%	48
2013 Q4	$572K	Sell	10,001 -568	-5%	-$31.2K	0.13%	53
2013 Q3	$628K	Sell	10,569 -8,830	-46%	-$482K	0.17%	50
2013 Q2	$1.05M	Buy	+19,399	New	+$913K	0.32%	46

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MDCM

Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $220M AUM 18.32% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wallace Capital Management's UTMD Position: Q3 2015 in Review

Wallace Capital Management sold out of Utah Medical Products (UTMD) in Q3 2015, closing a stake of 9,013 shares — an estimated $537K sold.

Wallace Capital Management first reported a position in UTMD in Q2 2013 and held it in 9 quarters. The position peaked at $1.05M in Q2 2013. 59 funds tracked by Wall St. Rank hold UTMD as of Q3 2015.

Wallace Capital Management reported no remaining Utah Medical Products position as of Q3 2015 after selling out during the quarter.
Wallace Capital Management sold 9,013 Utah Medical Products shares in Q3 2015, an estimated $537K.
Wallace Capital Management first reported a position in Utah Medical Products in Q2 2013 and held it in 9 quarters.
Wallace Capital Management's Utah Medical Products position peaked at $1.05M in Q2 2013.
59 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2015.

Based on Wallace Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.